Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

Voltage-gated Ion Channels

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

Voltage-gated Ion Channels

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrated serum metabolomics and lipidomics for identifying metabolic changes in rheumatoid arthritis.

Metabolomics : Official journal of the Metabolomic Society·2026

Same author

Salt-reducing pickering emulsions from <i>Zanthoxylum bungeanum</i> Maxim. byproducts: preparation and saltiness-enhancing mechanism.

Food chemistry: X·2026

Same author

Alcohol consumption and rheumatoid arthritis risk: A prospective cohort study with nonlinear Mendelian randomization analysis.

Alcohol, clinical & experimental research·2025

Same author

Unraveling the Link between Air Pollution and Psoriasis Subtypes: Genetic Architecture of Epigenetic Insights and Mediating Cytokines.

Environmental science & technology·2025

Same author

Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidney function biomarkers in the UK Biobank cohort.

Rheumatology (Oxford, England)·2025

Same author

Assessing Association Between Circulating Bilirubin Levels and the Risk of Frailty: An Observational and Mendelian Randomization Study.

Journal of cachexia, sarcopenia and muscle·2024

Search research articles

Related Experiment Video

Updated: May 14, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

[TREK1 potassium channels and depression].

Dong-Qing Ye¹, Zhi-Jun Zhang, Yang Li

¹Institute of Neurology and Psychiatry, Southeast University, Nanjing 210009, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica

|February 7, 2013

Summary

Major depression is a growing societal burden with unclear causes. The TREK1 potassium channel is a key target for antidepressants, influencing mood, neuronal protection, and plasticity.

Area of Science:

Neuroscience
Molecular Biology
Pharmacology

Context:

Major depressive disorder (MDD) poses a significant global health challenge.
The precise pathological mechanisms underlying MDD remain largely unknown.
TREK1 potassium channels are emerging as critical targets for antidepressant therapies.

Purpose:

To review the current understanding of TREK1 potassium channel structure and function.
To highlight the role of TREK1 in anti-depression, neuroprotection, and neuronal plasticity.
To explore the interactions between TREK1 and monoamine neurotransmitter systems.

Summary:

This review synthesizes research on the TREK1 potassium channel, a key player in MDD.
It details TREK1's involvement in mood regulation, neuronal health, and synaptic adaptability.

More Related Videos

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

Published on: July 15, 2025

Related Experiment Videos

Last Updated: May 14, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

Published on: July 15, 2025

The complex interplay between TREK1 and monoamine pathways is examined, alongside future research avenues.

Impact:

Provides a comprehensive overview of TREK1's therapeutic potential for depression.
Identifies critical mechanisms linking TREK1 to neurological functions relevant to MDD.
Suggests future research directions for developing novel antidepressant strategies targeting TREK1.